Post Profile






Related Posts


Intercept Pharmaceuticals Inc. (ICPT), Bristol-Myers Squibb Co (BMY), Biogen Idec Inc (BIIB): Orbimed Advisors Top Stocks in Q2

Business & Finance / Investing : Insider Monkey

Orbimed Advisors, led by Samuel Isaly, recently published its 13F filing with the U.S. Securities and Exchange Commission. For the second quarter of 2014, the hedge fund revealed 132 equity positions, worth $8.5 billion. Orbimed Adv...

Samuel Isaly, Orbimed Advisors Lower Position in NxStage Medical

Business & Finance / Investing : Insider Monkey

Samuel Isaly‘s hedge fund, Orbimed Advisors, decreased its stake in NxStage Medical, Inc. (NASDAQ:NXTM) to around 2.89 million shares, from 3.14 million held earlier. Following the decline in holdings, Orbimed’s position amasses 4.7...

Samuel Isaly, Orbimed Advisors Disclose Position in Post-IPO Relypsa

Business & Finance / Investing : Insider Monkey

Sam Isaly’s Orbimed Advisors disclosed its position in Relypsa Inc (NASDAQ:RLYP), a company that recently conducted its IPO. Orbimed reported holding around 3.2 million of Series B-1 Preferred Stock, and some 3.7 million of Series C...

Orbimed Advisors Further Cuts Exposure To Intercept Pharmaceuticals Inc. (ICPT)

Business & Finance / Investing : Insider Monkey

Orbimed Advisors, led by Samuel Isaly, has disclosed cutting its position in Intercept Pharmaceuticals Inc. (NASDAQ:ICPT). According to the filing, Orbimed Advisors sold 111,258 shares of the company at an average price of nearly $3...

Altisource Asset Management Corp (AAMC), Affimed Therapeutics BV (AFMD): Orbimed Advisors and Luxor Capital Group Are Bullish on These Companies

Business & Finance / Investing : Insider Monkey

Altisource Asset Management Corp (NYSEMKT:AAMC) and Affimed Therapeutics BV (NASDAQ:AFMD) felt hedge funds’ bullishness lately. Samuel Isaly’s Orbimed Advisors recently started a new position, with 5.81 million shares, at Affimed Th...

Comments


Copyright © 2016 Regator, LLC